Ascletis Pharma (HKSE:01672) Pre-Tax Income : HK$-280.47 Mil (TTM As of Jun. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Ascletis Pharma Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Ascletis Pharma's pretax income for the six months ended in Jun. 2024 was HK$-140.29 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-280.47 Mil. Ascletis Pharma's pretax margin was %.

During the past 8 years, Ascletis Pharma's highest Pretax Margin was -11.95%. The lowest was -2541.38%. And the median was -203.45%.

Ascletis Pharma Pre-Tax Income Historical Data

The historical data trend for Ascletis Pharma's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascletis Pharma Pre-Tax Income Chart

Ascletis Pharma Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

Get a 7-Day Free Trial

-106.79

-248.04

-243.69

-351.59

-158.29

Ascletis Pharma Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Pre-Tax Income	Get a 7-Day Free Trial											-103.15	-253.32	-18.11	-140.17	-140.29

Competitive Comparison of Ascletis Pharma's Pre-Tax Income

For the Biotechnology subindustry, Ascletis Pharma's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ascletis Pharma's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascletis Pharma's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Ascletis Pharma's Pre-Tax Income falls into.

Ascletis Pharma Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Ascletis Pharma's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-328.361	+	0	+	-0.158	+	108.588	+	61.645
	=	-158.29

Ascletis Pharma's Pretax Income for the quarter that ended in Jun. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-173.875	+	0	+	-0.121	+	51.756	+	-18.053
	=	-140.29

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-280.47 Mil.

Ascletis Pharma (HKSE:01672) Pre-Tax Income Explanation

Ascletis Pharma's Pretax Margin for the quarter that ended in Jun. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-140.293	/	0
	=	%

During the past 8 years, Ascletis Pharma's highest Pretax Margin was -11.95%. The lowest was -2541.38%. And the median was -203.45%.

Ascletis Pharma Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Ascletis Pharma's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascletis Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascletis Pharma Inc (HKSE:01672) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

ASCLF:USA 2VJ:Germany

Address

198 Qidi Road, 12th Floor, Building D, HIPARK, Xiaoshan District, Zhejiang Province, Hangzhou, CHN, 311200

Website

https://www.ascletis.com

Ascletis Pharma Inc is an investment holding company. Along with its subsidiaries, it is engaged in the research and development, production, marketing, and sale of pharmaceutical products. It has three marketed products, i.e. Ritonavir tablets, GANOVO, and ASCLEVIR. It also has other drug candidates in its pipeline in their different stages of development such as ASC22, ASC10, ASC11, and ASC40 among others. Geographically, it operates in Mainland China and other countries.

Executives

Jjw12 Limited
Lakemont Holding Llc
Wu Jinzi Jason	2101 Beneficial owner
Wu Judy Hejingdao	2101 Beneficial owner
Jjw11 Limited
C-bridge Capital Gp, Ltd.	2201 Interest of corporation controlled by you
Fu Wei	2201 Interest of corporation controlled by you
Tf Capital Ii Ltd.	2201 Interest of corporation controlled by you
Tf Capital, Ltd.	2201 Interest of corporation controlled by you
Kang Hua Investment Company Limited	2201 Interest of corporation controlled by you
Yang Dan	2201 Interest of corporation controlled by you

Ascletis Pharma Headlines

No Headlines